How COVID-19 Compromised U.S. Gains in Controlling HIV
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
University of California San Francisco
Give to UCSFThe COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years.
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.